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Edited by Hans-Dieter KlenkAbstract One way herpes simplex virus type-1 (HSV-1) spreads
in vivo is by polykaryocytes formation. Here we demonstrate that
polykaryocyte production during HSV-1 spread in cultured
human corneal ﬁbroblasts (CF) required heparan sulfate (HS)
and more speciﬁcally 3-O sulfated HS (3-OS HS). The polykar-
yocyte formation heavily depended on the expression of HS on
target (CF) cells but not on glycoprotein expressing eﬀector cells.
Furthermore, we provide the ﬁrst visual evidence of 3-OS HS and
HSV-1 gD colocalization during the membrane fusion process.
Taken together our results provide novel insight into the signiﬁ-
cance of HS in polykaryocyte formation.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Cell surface heparan sulfate (HS) glycosaminoglycans
(GAG) contain alternating disaccharide units of uronic acid
and N-acetylglucosamine. During biosynthesis, HS is modiﬁed
by multiple enzymes including a last 3-O sulfation step
that requires 3-O sulfotransferases (3-OSTs) [1,2]. These
modiﬁcations not only add molecular diversity to HS but also
provide speciﬁc binding sites for a variety of proteins including
entry receptors for many viruses [3–6].
In case of herpes simplex virus type-1 (HSV-1), it was ﬁrst
proposed that HS chains can serve as an initial attachment site
for the viral envelope glycoproteins gB and gC [1,7]. Subse-
quent insights into the role of HS revealed that modiﬁcation
of HS by 3-OSTs (except isoform-1) can result in generation
of 3-O sulfated HS (3-OS HS) [8–12]. The 3-OS HS can act
as a receptor for gD, a glycoprotein necessary for HSV-1 entry
into cells [2]. The ability to bind gD is acquired when HS
chains contain at least one of the following disaccharides,Abbreviations: HS, heparan sulfate; 3-OST, 3-O- sulfotransferase; 3-
OS HS, 3-O sulfated heparan sulfate; CF, corneal ﬁbroblasts; HSV-1,
herpes simplex virus type-1
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doi:10.1016/j.febslet.2007.08.029-IdoA2S-GlcNH23S6S- or -IdoA2S-GlcNH23S- [2]. Corneal
ﬁbroblasts (CF), a primary cell type cultured from the human
cornea, are known to express 3-OS HS speciﬁc disaccharides
[13,14].
HSV-1 infection of the cornea, especially the inner layer or
stroma from where the CFs were isolated, can result in signif-
icant vision loss and is considered a leading infectious cause of
blindness [15]. The corneal herpetic lesions can contain poly-
karyocytes that are formed by membrane fusion of infected
cells with neighboring uninfected cells induced by viral glyco-
proteins [16]. Although the polykaryocyte formation is consid-
ered an important means of viral spread and a clue for HSV-1
keratitis [16–20] its mechanism remains poorly understood for
natural target cell types such as human CF. To increase our
understanding of the mechanism, the current study focuses
on the role of HS and uniquely modiﬁed HS chains in this phe-
nomenon. While studies in the past have suggested no signiﬁ-
cant role of HS [19,21], we provide evidence to suggest that HS
is required by primary cultures of human CF to form poly-
karyocytes. We also demonstrate the presence of 3-OS HS at
the cell-to-cell contact sites during membrane fusion.2. Materials and methods
2.1. Cell cultures
As previously described [22], cultures of human CF were derived
from the stroma of corneal tissues obtained from the Illinois Eye Bank,
Chicago, IL, using institution approved protocol and culture condi-
tions in accordance with the Declaration of Helsinki. CF from the
3rd passage was used for the study. P.G. Spear (Northwestern Univer-
sity, Chicago) provided wild-type CHO-K1 cells and CHO-745 cells
that are deﬁcient in HS or GAG biosynthesis. Both wild-type CHO-
K1 cells and CHO-745 cells were grown in Ham’s F12 (Invitrogen
Corp, Carlsbad, CA) supplemented with 10% FBS.
2.2. Plasmids
The plasmids used in this study were pPEP98 (gB), pPEP99 (gD),
pPEP100 (gH) and pPEP101 (gL) that express HSV-1 glycoproteins,
plasmid pT7EMCLuc that express ﬁreﬂy luciferase gene under T7 pro-
moter, plasmid pCAGT7 that expresses T7 RNA polymerase [19].
HSV-1 gD receptor plasmid pDS43 that expresses 3-OST-3B [2] and
nectin-1 (pBG38) were also used. The control plasmid, pCDNA3.1,
was purchased from Invitrogen (Carlsbad, CA, USA).
2.3. Cell fusion assays and estimation of polykaryocytes
Cell fusion assays were performed as described previously [8,11,17–
20]. Brieﬂy, the CHO-K1 cells and/or CHO-745 cells designated ‘‘eﬀec-
tor’’ cells were co-transfected using Lipofectamine (Gibco/BRL) withblished by Elsevier B.V. All rights reserved.
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(0.5 lg DNA of each plasmid). The cultured CF cells or ‘‘target’’ cells
grown up to 50–60% conﬂuency were cotransfected with pCAGT7 that
expresses T7 RNA polymerase [19]. The eﬀector cells expressing
pT7EMCLuc and pcDNA3.1 and the target cells expressing 3-OST-3
with T7 RNA polymerase were considered as controls. A group of
multinucleated cells (10 or more nuclei) were scored positive for poly-
karyocytes formation.
2.4. Cell surface immunoﬂuorescence assay
Both cultured CF and HSV-1 glycoprotein-expressing CHO-K1 cells
were co-cultured in chamber polystyrene vessels (BD Falcon) at
around 30% conﬂuency. Cells were then incubated with primary anti-
bodies at 4 C for 45 min, washed 10 times with cold PBS, and ﬁxed
with acetone for 10 min at 20 C. The primary antibodies used were
rabbit polyclonal (R7) to HSV-1 gD (kindly provided by R. Eisenberg
and G. Cohen, University of Pennsylvania) diluted 1:20000 in PBS/
10% normal goat serum (NGS) and the anti 3-OS HS mouse monoclo-
nal antibody [23] diluted 1:100 in PBS/10% NGS with 0.5 M NaCl.Fig. 1. (A) Microscopic visualization of HSV-1 glycoproteins induced polyka
with expression constructs for HSV-1 glycoproteins (gB, gD, and gH-gL) wer
OST-3 (panel b) or CF (panel c). The corresponding control eﬀector cells we
nectin-1 (panel d), 3-OST-3 (panel e) or CF (panel f). After 24 h, the cells
temperature for 30 min and stained with Giemsa stain (Fluka) for 20 min. Sho
polykaryocyte formation. Eﬀector cells were transfected with gB, gD, and gH
dishes with target cells as indicated. The polykaryocytes were stained (as de
considered a polykaryocyte. (C) Expression of gB, gD and gH-gL is required
for glycoproteins indicated and mixed with CF. Membrane fusion due to po
Relative luciferase units (RLUs) determined using a Sirius luminometer (BerAfter ﬁxation, cells were dried at room temperature for 5 min, blocked
in PBS/10% calf serum, and incubated with secondary antibody: anti-
mouse polyclonal FITC conjugated (1:500 dilution) or anti-rabbit
polyclonal with H&L Texas Red-conjugated (1:5000 dilution) for
45 min at 37 C. The cells were again washed in PBS before mounting
in Vectashield mounting medium (Vector Laboratories, Inc.Burlin-
game, CA). Leica confocal microscope SP2 was used for sequential
scanning of the samples.3. Results and discussion
The ability of CF to use its endogenous gD receptor to form
polykaryocytes with HSV-1 glycoprotein expressing CHO-K1
cells was examined. These cells express cell surface HS but lack
functional gD receptors, including 3-OS HS [2]. As a result,
they are resistant to both HSV-1 entry and virus induced mem-ryocyte formation in CF. Wild-type CHO-K1 eﬀector cells transfected
e co-cultured with target CHO-K1 cells expressing nectin-1 (panel a), 3-
re transfected with an empty vector pCDNA3.1 and co-cultured with
were ﬁxed with 2% formaldehyde and 0.2% glutaraldehyde at room
wn are photographs of representative cells. (B) Quantitative analysis of
-gL (dark bars) or pCDNA3.1 (empty bars) and co-cultured in 24-well
scribed above) and counted. Cells containing 10 or more nuclei were
. The eﬀector CHO-K1 cells were transfected with expression plasmids
lykaryocyte formation was detected by monitoring Luciferase activity.
thold detection systems).
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mixing ‘‘target’’ CF with HSV-1 glycoproteins (gB, gD, gH,
gL)-expressing ‘‘eﬀector’’ cells [17–20]. The polykaryocytes
formed by CF was compared with those seen with 3-OST-3-
expressing and nectin-1-expressing cells. Two set of positive
control cells were selected because CF expresses 3-OST-3 but
not nectin-1, which is a relatively common receptor for
HSV-1 [13,14,24]. As a negative control, mock eﬀector cells
transfected with empty vector (pCDNA3.1) were used. As
shown in Fig. 1A (panels a–c), polykaryocytes with sizes sim-
ilar to those in nectin-1 or 3-OST-3- expressing CHO-K1 cells
were detected in CF. During the same time interval, little, if
any, polykaryocyte formation was detected in control
(pCDNA3.1) cells (Fig. 1A, panels d–f). It was also evident
(Fig. 1B; solid bars) that the average number of polykaryo-
cytes (with 10 or more nuclei) formed in one well of a 6-well
cell culture dish was very similar in all three types of cells
examined. These results demonstrate that the four glycopro-
teins (gB, gD, and gH-gL) are suﬃcient for comparable level
of polykaryocyte formation to occur in CF against nectin-1
or 3-OST-3-expressing cells.
Next, we decided to determine which glycoproteins were
essential for fusion of primary cultures of CF with the eﬀector
cells. We transfected eﬀector CHO-K1 cells with various com-
binations of HSV-1 glycoproteins and performed a luciferase
reporter (Promega, Madison, WI) based cell-to-cell fusion
assay [19]. As shown in Fig. 1C, it was clear that fusion of
cultured CF required expression of all four glycoproteins,Fig. 2. (A,B) Enzymatic removal of HS blocks polykaryocyte formation. (A
untreated prior to co-cultivation with eﬀector CHO-K1 cells expressing gB,
treated with heparinase or untreated was quantitated. Both eﬀectors and targ
well dishes. Cells with 10 or more nuclei were counted. (C,D) HS is required b
as eﬀector cells with the target cells as indicated. Heparinase treated or untrea
as described above (D).gB, gD, gH, and gL in eﬀector cells [17–20]. In the absence
of any of the four glycoproteins luciferase signals were identi-
cal to the background (no glycoproteins). Next, we sought to
determine the role of HS in polykaryocyte formation. We
hypothesized that since cultured CFs express 3-OS HS as the
gD receptor [13], HS in general will be required for polykaryo-
cyte formation. In order to test this hypothesis we examined
the eﬀect of HS degrading enzyme, heparinase-I. Along with
CF, nectin-1 and 3-OST-3-expressing CHO-K1 cells were used
as controls. The experiment was performed by dividing each
type of the target cell population (CF, nectin-1 or 3-OST-3-
expressing CHO-K1) into two equal pools. Heparinase-I
(1.5 U ml1, Sigma) was added to one pool while the other
pool was compensated with identical volume of phosphate-
buﬀered saline (PBS) [2]. Both treated and untreated pools
were then mixed with equal amounts of eﬀector cells and co-
cultivated. As shown in Fig. 2A, heparinase treatment drasti-
cally impaired the ability of CF and 3-OST-expressing CHO-
K1 to from giant multinucleated cells. By contrast, heparin-
ase-I treatment had virtually no eﬀect on the fusion of nec-
tin-1 expressing CHO-K1 cells, which is in line with the fact
that nectin-1 mediated cell fusion does not depend on HS
expression [21]. Likewise, the number of polykaryocytes
formed was signiﬁcantly lowered upon heparinase treatment
of 3-OST-3 expressing CHO-K1 cells and CF but not when
nectin-1 cells were treated. This indicates that CF and as
expected, CHO-K1 3-OST-3 cells, exhibit heavy dependence
for polykaryocyte formation on HS expression, implicating) Target cells (as indicated) were either treated with heparinase I or left
gD, gH-gL. (B) The number of polykaryocytes formed in target cells
et cells were mixed in 1:1 ratio and cultured for additional 16 h in a 24
y target but not the eﬀector cells. HS negative CHO-745 cells were used
ted cells were visualized for polykaryocyte formation (C) and quantiﬁed
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In subsequent experiments we investigated whether the eﬀec-
tor, target or both types of cells require HS expression. To
determine this we made use of a mutant CHO cell line
(CHO-745) that is defective in HS or GAG biosynthesis [2].
The CHO-745 cells transiently expressing the four glycopro-
teins (gB, gD, gH, gL) were co-cultured with either CF or wild
type CHO-K1 cells that express nectin-1 or 3-OST-3. The cells
were either treated with heparinase or un-treated. Since the
eﬀector cells used here naturally lack HS, it was reasoned that
if HS expression was required for the eﬀector cells, we should
observe a signiﬁcant decrease in the size and the number of
polykarocytes formed in the untreated cells. On the other
hand, if HS expression was needed only for target cells that
use 3-OS HS as the gD receptor then a treatment with heparin-
ase should reduce polykaryocyte formation. As seen in Fig. 2C
and D untreated cells in each case formed polykaryocytes that
were similar in size and numbers and thus, ruled out any sig-
niﬁcant need of HS expression for eﬀector cells. A signiﬁcant
diﬀerence was seen in the case of treated cells. While nectin-
1-expressing cells were largely unaﬀected by the treatment,
both CF and 3-OST-3-expressing cells exhibited a marked
reduction in the size and the number of polykaryocytes formed
upon heparinase treatment. This data, therefore, suggests that
HS expression on the target cell is important, which further af-
ﬁrms the possibility that 3-OS HS is the mediator required for
making contacts for fusion with gD on the eﬀector cells. Final-Fig. 3. (A–F). Sequential confocal analyses demonstrating co-localization o
performed as described in the text. 3-OS HS was detected with an anti-3-OS H
anti-body (green), gD with a rabbit polyclonal antibody (R7) and a Texas
channels demonstrates the colocalization (yellow).ly, to determine the expression of 3-OS HS on CF and to con-
ﬁrm that it is co-localized with HSV-1 gD expressed on eﬀector
cells we performed immunocytochemistry. The target cells
(CF) were cocultured with eﬀector cells and ﬁxed. A primary
monoclonal antibody (HS4C3) that speciﬁcally recognizes 3-
OS HS [23] was used in combination with an anti-gD poly-
clonal antibody (R7). The primary antibodies were detected
by corresponding secondary antibodies conjugated with FITC
(for 3-OS HS detection) or Texas Red (for gD detection). As
shown in Fig. 3B, 3-OS HS was detected on CF (green) and
gD (red) on the eﬀector cells (Fig. 3C). It was also evident
(Fig. 3D) that gD and 3-OS HS colocalized (yellow) at the
cell-to-cell contact sites for fusion. The insets in Fig. 3 are
shown at a higher magniﬁcation in the lower panels to high-
light the gD and 3-OS HS colocalization (Fig. 3E–G). Overall,
the colocalization suggests a possible interaction between 3-OS
HS and gD, which may lead to the membrane fusion.
In summary, our study demonstrates for the ﬁrst time the
signiﬁcance of HS in general and 3-OS HS in particular in pol-
ykaryocyte formation. Also for the ﬁrst time, using a speciﬁc
monoclonal antibody against 3-OS HS [23] we demonstrate
its co-localization with gD on cell-to-cell contact sites. In addi-
tion, our results revise previous indications that HS has no sig-
niﬁcant role in this process [19,21]. Obviously, HS may not be
necessary for polykaryocyte formation by all cell types, but it
clearly can prove important for certain natural target cell types
such as CF, where the virus can use it for entry [13,14] and cell-f HSV-1 gD with 3-OS HS. The fusion assay and the staining were
S monoclonal antibody, HS4C3 [23] and a FITC conjugated secondary
Red conjugated secondary antibody. The merging of green and red
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our work is ampliﬁed by the fact that many viruses of diﬀerent
families have also been found to interact with HS [6]. These in-
clude the Picornaviridae (foot-and-mouth disease virus), Toga-
viridae (Sindbis virus and dengue virus), Parvoviridae (adeno-
associated virus 2), Poxviridae (vaccinia virus), Retroviridae
(human immunodeﬁciency virus) and Herpesviridae (virtually
all human herpesviruses) [1,6]. Our study, therefore, opens
the door for future studies analyzing the signiﬁcance of HS
and more speciﬁcally, 3-OS HS, in other virus-induced mem-
brane fusion mechanisms as well.
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